£67 million upgrade underway at GSK's Montrose facility
Jan 15, 2024 · GSK is planning to invest £200m in its UK manufacturing operations over the next two years. The pharmaceutical giant is currently in the middle of a multi-year £67m upgrade to its Montrose site, which includes a new facility which is set to be completed this year.
New £44m facility at GSK Montrose - gov.scot - The Scottish …
Aug 15, 2017 · First Minister Nicola Sturgeon welcomed GSK’s (GlaxoSmithKline) commitment to Montrose as she opened their new £44 million aluminium salts facility. The site produces ingredients for vaccines for illnesses including tetanus, pneumonia and whooping cough.
Pharma giant GSK's new £44m facility in Montrose ... - The National
Aug 16, 2017 · NICOLA Sturgeon has opened a new £44 million facility for pharma giant GSK (GlaxoSmithKline) in Angus which will produce 400 million vaccines every year. GSK’s aluminium salts unit in Montrose makes ingredients for vaccines for various illnesses, including tetanus, pneumonia and whooping cough.
GSK invests in Montrose - gov.scot - The Scottish Government
Oct 22, 2018 · GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building which is the second multi-million investment in the Montrose site over the last two years.
Pharma giant GSK says Montrose key to global operations - The …
Oct 6, 2024 · Pharma giant GSK reveals why Montrose key to global operations amid its £67 million investment in the area. A £67 million upgrade is currently under way at GlaxoSmithKline's Montrose...
GlaxoSmithKline opens new $56.6M vaccines plant in Scotland
Aug 15, 2017 · GlaxoSmithKline opened its new $56.6 million vaccines plant in Montrose, Scotland, that will manufacture sterile aluminum salts and includes a microbiology lab. But the small addition comes as a...
GSK affirms its long-term commitment to manufacturing in Scotland
Built at a cost of £44M, the new facility at GSK’s site at Montrose in north-east Scotland will manufacture sterile aluminium salts which are compounds that boost the human body’s response to vaccines and supply them to GSK’s vaccine factories around the world.
Nicola Sturgeon opens new £54m GlaxoSmithKline centre
Oct 22, 2018 · Nicola Sturgeon officially opened GlaxoSmithKline's £44m facility on the site last year. A £54 million pharmaceutical production centre has been opened by the First Minister. GlaxoSmithKline (GSK) will use the building in Montrose, Angus, to …
GSK invests in Montrose - Life Sciences Scotland
Oct 22, 2018 · GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building and it is the second multi-million investment on the Montrose site over the last two years.
Nicola Sturgeon officially opens GlaxoSmithKline's £44m Montrose …
Aug 15, 2017 · Nicola Sturgeon has officially opened GlaxoSmithKline's new £44 million aluminium salts facility at its site in Montrose. The new facility includes a microbiology laboratory, will manufacture sterile aluminium salts – compounds which …